$1.6 Million Grant Examines Impact of Antipsychotic Drug Reductions in Long-Term Care Facilities

Linda Wastila

Linda Wastila, BSPharm, MSPH, PhD, the Parke-Davis Chair in Geriatric Pharmacotherapy in the Department of Pharmaceutical Health Services Research at the University of Maryland School of Pharmacy, has received a three-year, $1.6 million grant from the National Institutes of Health to investigate how a recent nationwide initiative to reduce the use of antipsychotic medications among older adults in long-term care facilities has impacted the use of other medications at those facilities, as well as patient health outcomes.

“The organizations involved in this initiative have done an excellent job reporting the reductions in the use of antipsychotics, but our team will be the first to examine how efforts to reduce the use of this class of medications impacts the use of other medications and health outcomes for older adults in long-term care facilities,” says Wastila, who also serves as the director of research for the Peter Lamy Center on Drug Therapy and Aging at the School. “We hope reductions in the use of antipsychotics are favorable for these patients, but this study will allow us, as drug safety experts, to truly quantify to real world impact of this initiative.”

Check out the full article at http://news.pharmacy.umaryland.edu/1-6-million-grant-examines-impact-of-antipsychotic-drug-reductions-in-long-term-care-facilities/